Browse

S-Space

Browsing by Author 3321

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 60 of 319

Issue Date Title / Author(s) / CitationFileAltmetrics
2002-07
Colorectal cancer in Korea: characteristics and trends

Kim, Dong-Wan; Bang, Yung-Jue; Heo, Dae Seog; Kim, Noe Kyeong

Tumori, Vol.88 No.4, pp.262-265

DOI
2003-12
Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: Methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone
DOI
2003-12
Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients - Comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage
DOI
2004-06
Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies
DOI
2004-06
Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients

Lee, June-Chul; Lee, Kyung-Mi; Kim, Dong-Wan; Heo, Dae Seog

Journal of Immunology, Vol.172 No.12, pp.7335-7340

DOI
2004-07
Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy
DOI
2004-11
A multi-center, late phase II clinical trial of Genexol (R) (paclitaxel) and cisplatin for patients with advanced gastric cancer
DOI
2004-11
Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma
DOI
2005-01
Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa (R), ZD1839) in chemotherapy-resistant non-small cell lung cancer
link
2005-01
Paclitaxel/platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer
link
2005-04
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib
DOI
2005-07
Docetaxel+5-fluorouracil plus cisplatin 3-day combination chemotherapy as a first-line treatment in patient with unresectable gastric cancer
link
2005-07
Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer
DOI
2005-10
Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer
view fileDOI
2005-12
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer
link
2005-12
Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I-E/IIE extranodal NK/T-cell lymphoma, nasal type
link
2006-02
CPR or DNR? End-of-life decision in Korean cancer patients: a single center's experience
link
2006-03
Antibiotic use during the last days of life in cancer patients

Oh, D. Y.; Kim, J. H.; Kim, D. W.; Im, S. A.; Kim, T. Y.; Heo, D. S.; Bang, Y. J.; Kim, N. K.]

European Journal of Cancer Care, Vol.15 No.1, pp.74-79

DOI
2006-04
Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation
DOI
2006-06
Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer
link
2006-07
High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy
link
2006-08
Primary systemic anaplastic large cell lymphoma in a single Korean institution: Clinical characteristics and treatment outcome
view filelink
2006-11
Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients
DOI
2007-04
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
view fileDOI
2007-05
Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer
DOI
2007-06
Artificial nutrition and hydration in terminal cancer patients: the real and the ideal
link
2007-09
Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer
view filelink
2007-10
Palliative chemotherapy for pulmonary pleomorphic carcinoma
DOI
2007-11
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
view filelink
2007-12
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer
link
2008-01
A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer
link
2008-02
Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma
link
2008-02
Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer
DOI
2008-03
Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer
link
2008-05
Aggressiveness of cancer-care near the end-of-life in Korea

Keam, Bhumsuk; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Mi Ra; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Heo, Dae Seog]

Japanese Journal of Clinical Oncology, Vol.38 No.5, pp.381-386

link
2008-05
Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker
view filelink
2008-05
A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker
DOI
2008-06
ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
DOI
2008-07
Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatment
DOI
2008-11
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives
link
2008-12
Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients
DOI
2008-12
Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
view filelink
2009-01
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone
DOI
2009-03
The role of PET/CT in detection of gastric cancer recurrence
view fileDOI
2009-03
Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival
DOI
2009-05
Preradiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: A retrospective analysis
view fileDOI
2009-07
Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy
link
2009-07
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI
DOI
2009-08
Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer
link
2009-08
Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin
DOI
2009-08
Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma
DOI
2009-08
Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma
DOI
2009-09
Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement
DOI
2009-10
Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma
DOI
2009-11
Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and beta III-Tubulin Between Primary Non-small Cell Lung Cancer and Metastatic Lymph Nodes and the Significance in Mid-Term Survival
DOI
2009-12
Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy
view fileDOI
2010-02
Timing of local and distant failure in resected lung cancer: Implications for reported rates of local failure

Boyd, Jessamy A.; Hubbs, Jessica L.; Kim, Dong-Wan; Hollis, Donna; Marks, Lawrence B.; Kelsey, Chris R.

Journal of Thoracic Oncology, Vol.5 No.2, pp.211-214

DOI
2010-03
Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer
DOI
2010-03
An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity
DOI
2010-05
First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective analysis of clinical predictors
view fileDOI
1 2 3 4 5 66

Seoul National University Library, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea TEL: 02-880-5567 Email: s-space@snu.ac.kr youtube

RSS 1.0 RSS 2.0 Atom

Hello

Browse

News About S-Space Seoul National University Library LOGIN